Elżbieta Iskierka‐Jazdzewska

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

Mingfeng Zhang, Zhaoming Wang, Ofure Obazee et al. · Oncotarget · 2016 · 112 citations · Full text

Life Sciences, Genetics, Oncology +12

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

Tae Min Kim, Michał Taszner, Silvana Novelli et al. · Annals of Oncology · 2024 · 76 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Sabarish Ayyappan, Won Seog Kim, Tae Min Kim et al. · Blood · 2023 · 48 citations

Medicine, Oncology, Pharmacotherapy +12

Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Won Seog Kim, Tae Min Kim, Seok‐Goo Cho et al. · Nature Cancer · 2025 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

Elżbieta Iskierka‐Jazdzewska, Marek Hus, Krzysztof Giannopoulos et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 39 citations

Medicine, Oncology, Pharmacology +14